Data as of November 4, 2026
Nextstellis 3-14.2 mg Tablet
DROSPIRENONE AND ESTETROL
Brand: Nextstellis
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$321.26/ fill$7.65 / EA
Medicaid FFS
$366.47/ fill
Medicaid MCO
$276.07/ fill
Sources: cms/nadac:price-ladder · cms/sdud
What's in the reimbursement
Ingredient cost (42 units/fill)$321.26
Dispensing fee & other (state-fixed, not margin)$45.21
Total reimbursed per fill$366.47
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 12 fee-for-service states, 21 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology